AstraZeneca, Oxford show the value of transparency



[ad_1]

The crown vaccine from AstraZeneca and the University of Oxford has been approved for the first time, again in the UK. However, with an irritating procedure, the developers raised questions and put valuable trust at risk.

The tests on the efficacy of the AstraZeneca vaccine initially yielded difficult-to-understand results.

The tests on the efficacy of the AstraZeneca vaccine initially yielded difficult-to-understand results.

Francis Mascarenhas / Reuters

The UK became the first country to approve the corona vaccine from AstraZeneca and the University of Oxford on Wednesday. The vaccination should start in a few days. Britain was the first Western country to approve the Biontech / Pfizer vaccine in early December. Now London has enough doses of an approved vaccine in the offing to vaccinate the entire adult population. This is important because the new coronavirus mutation is causing the number of infections to skyrocket in England, and hospitals are already under significant pressure. The AstraZeneca and Oxford product will also play a decisive role for the rest of the world: it can be stored at refrigerator temperature, making it easier to distribute and much cheaper than the Biontech or Moderna products, due to the type of production. and because it is sold at cost price. be.

[ad_2]